NatWest Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-6,873
| Closed | -$724K | – | 157 |
|
|
2015
Q3 | $724K | Buy |
+6,873
| New | +$724K | 0.02% | 226 |
|
|
2015
Q2 | – | Sell |
-6,873
| Closed | -$857K | – | 383 |
|
|
2015
Q1 | $857K | Sell |
6,873
-1,402
| -17% | -$175K | 0.01% | 237 |
|
|
2014
Q4 | $748 | Sell |
8,275
-9,986
| -55% | -$903 | 0.01% | 248 |
|
|
2014
Q3 | $1.32K | Buy |
18,261
+1,204
| +7% | +$87 | 0.01% | 227 |
|
|
2014
Q2 | $1.06M | Buy |
17,057
+1,911
| +13% | +$119K | 0.04% | 258 |
|
|
2014
Q1 | $1.03M | Sell |
15,146
-75
| -0.5% | -$5.12K | 0.05% | 242 |
|
|
2013
Q4 | $1.07M | Sell |
15,221
-1,487
| -9% | -$105K | 0.03% | 421 |
|
|
2013
Q3 | $1.21M | Sell |
16,708
-3,007
| -15% | -$217K | 0.04% | 366 |
|
|
2013
Q2 | $1.1M | Buy |
+19,715
| New | +$1.1M | 0.02% | 447 |
|